Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Trends in Molecular Medicine|December 23, 2018
Microglia in Central Nervous System Inflammation and Multiple Sclerosis PathologySofie Voet, Marco Prinz, Geert van LooEMBO Molecular Medicine|April 25, 2019
Inflammasomes in neuroinflammatory and neurodegenerative diseasesSofie Voet, Sahana Srinivasan, Mohamed Lamkanfi, et al.The Journal of Investigative Dermatology|February 19, 2017
S100B Is a Potential Disease Activity Marker in Nonsegmental VitiligoReinhart Speeckaert, Sofie Voet, Esther Hoste, et al.Journal of Neuroinflammation|July 22, 2014
Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosisConor Mc Guire, Lynn Elton, Peter Wieghofer, et al.Cell Reports|February 21, 2020
OTULIN Prevents Liver Inflammation and Hepatocellular Carcinoma by Inhibiting FADD- and RIPK1 Kinase-Mediated Hepatocyte ApoptosisLien Verboom, Arne Martens, Dario Priem, et al.Nature Immunology|March 25, 2020
Two distinct ubiquitin-binding motifs in A20 mediate its anti-inflammatory and cell-protective activitiesArne Martens, Dario Priem, Esther Hoste, et al.Nature Communications|October 8, 2015
Cardiovascular and pharmacological implications of haem-deficient NO-unresponsive soluble guanylate cyclase knock-in miceRobrecht Thoonen, Anje Cauwels, Kelly Decaluwe, et al.Frontiers in Immunology|February 14, 2024
Inflammasome signaling is dispensable for ß-amyloid-induced neuropathology in preclinical models of Alzheimer's diseaseSahana Srinivasan, Daliya Kancheva, Sofie De Ren, et al.Nature Communications|May 24, 2018
A20 critically controls microglia activation and inhibits inflammasome-dependent neuroinflammationSofie Voet, Conor Mc Guire, Nora Hagemeyer, et al.Science Immunology|January 30, 2026
Cross-species cellular mapping and humanization of Fcγ receptors to advance antibody modelingKarel F A Van Damme, Dorine Sichien, Katrien Van der Borght, et al.Pageof 1